Ensign Peak Advisors’s Vera Therapeutics VERA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Hold |
13,550
| – | – | ﹤0.01% | 1646 |
|
|
2025
Q1 | $325K | Hold |
13,550
| – | – | ﹤0.01% | 1634 |
|
|
2024
Q4 | $573K | Buy |
13,550
+1,800
| +15% | +$76.1K | ﹤0.01% | 1558 |
|
|
2024
Q3 | $519K | Hold |
11,750
| – | – | ﹤0.01% | 1598 |
|
|
2024
Q2 | $425K | Buy |
11,750
+1,400
| +14% | +$50.7K | ﹤0.01% | 1640 |
|
|
2024
Q1 | $446K | Buy |
+10,350
| New | +$446K | ﹤0.01% | 1648 |
|
|
2023
Q4 | – | Sell |
-17,816
| Closed | -$244K | – | 1762 |
|
|
2023
Q3 | $244K | Hold |
17,816
| – | – | ﹤0.01% | 1717 |
|
|
2023
Q2 | $286K | Hold |
17,816
| – | – | ﹤0.01% | 1717 |
|
|
2023
Q1 | $138K | Hold |
17,816
| – | – | ﹤0.01% | 1750 |
|
|
2022
Q4 | $345K | Sell |
17,816
-3,300
| -16% | -$63.9K | ﹤0.01% | 1695 |
|
|
2022
Q3 | $450K | Buy |
21,116
+7,839
| +59% | +$167K | ﹤0.01% | 1514 |
|
|
2022
Q2 | $181K | Hold |
13,277
| – | – | ﹤0.01% | 1827 |
|
|
2022
Q1 | $312K | Buy |
+13,277
| New | +$312K | ﹤0.01% | 1737 |
|